Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

atlantic laboratories (m) sdn. bhd. - chlorpheniramine maleate -

United States - English - NLM (National Library of Medicine)

teva pharmaceuticals usa, inc. - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amiloride hydrochloride anhydrous 5 mg - amiloride hydrochloride and hydrochlorothiazide tablets are indicated in those patients with hypertension or with congestive heart failure who develop hypokalemia when thiazides or other kaliuretic diuretics are used alone, or in whom maintenance of normal serum potassium levels is considered to be clinically important, e.g., digitalized patients, or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hydrochloride and hydrochlorothiazide tablets may be used alone or as an adjunct to other antihypertensive drugs, such as methyldopa or beta blockers. since amiloride hydrochloride and hydrochlorothiazide enhances the action of these agents, dosage adjustments may be necessary to avoid an excessive fall in blood pressure and other unwanted side effects. the fixed combination drug is not indicated for the initial therapy of edema or hypert

United States - English - NLM (National Library of Medicine)

a-s medication solutions - amiloride hydrochloride (unii: fzj37245uc) (amiloride - unii:7dzo8eb0z3), hydrochlorothiazide (unii: 0j48lph2th) (hydrochlorothiazide - unii:0j48lph2th) - amiloride hydrochloride anhydrous 5 mg - amiloride hydrochloride and hydrochlorothiazide tablets are indicated in those patients with hypertension or with congestive heart failure who develop hypokalemia when thiazides or other kaliuretic diuretics are used alone, or in whom maintenance of normal serum potassium levels is considered to be clinically important, e.g., digitalized patients, or patients with significant cardiac arrhythmias. the use of potassium-conserving agents is often unnecessary in patients receiving diuretics for uncomplicated essential hypertension when such patients have a normal diet. amiloride hydrochloride and hydrochlorothiazide tablets may be used alone or as an adjunct to other antihypertensive drugs, such as methyldopa or beta blockers. since amiloride hydrochloride and hydrochlorothiazide enhances the action of these agents, dosage adjustments may be necessary to avoid an excessive fall in blood pressure and other unwanted side effects. the fixed combination drug is not indicated for the initial therapy of edema or hypert

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

open joint stock company "borisovskiy zavod medicinskikh preparatov" - chloropyramine (chloropyramine hydrochloride) - solution for i/v and i/m injection - 20mg/ml

Armenia - English - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

open joint stock company "borisovskiy zavod medicinskikh preparatov" - chloropyramine (chloropyramine hydrochloride) - solution for i/v and i/m injection - 20mg/ml

Canada - English - Health Canada

orbus pharma inc - amiloride hydrochloride - tablet - 5mg - amiloride hydrochloride 5mg - potassium-sparing diuretics

Australia - English - Department of Health (Therapeutic Goods Administration)

alphapharm pty ltd - amiloride hydrochloride dihydrate, quantity: 5 mg - tablet, uncoated - excipient ingredients: maize starch; povidone; lactose monohydrate; microcrystalline cellulose; magnesium stearate - indications as at 15 july 1998 : kaluril's main indication is as concomitant therapy with diuretics to conserve potassium during periods of vigorous diuresis and during long-term maintenance therapy with thiazides or other more potent diuretics. kaluril when used alone, has mild diuretic and antihypertensive activity. oedema of cardiac origin. although kaluril alone may provide adequate diuresis for some patients with oedema of cardiac origin, it is primarily indicated for concomitant use in patients receiving thiazides or more potent saluretic diuretic agents. in these patients it may provide increased sodium, chloride and water excretion and decreased potassium excretion. the positive effect of kaluril on potassium balance may be especially important for digitalised cardiac patients, in whom potassium depletion sensitises or exaggerates the response of the heart to the toxic effects of digitalis (e.g. increased ventricular irritability), which may precipitate digitalis intoxication with potentially seriou

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - amiloride hydrochloride; cyclopenthiazide - oral tablet - 2.5mg ; 250microgram

New Zealand - English - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - amiloride hydrochloride dihydrate 5mg;  ; hydrochlorothiazide 50mg - tablet - 50mg/5mg - active: amiloride hydrochloride dihydrate 5mg   hydrochlorothiazide 50mg excipient: calcium hydrogen phosphate guar gum lactose magnesium stearate maize starch pregelatinised maize starch sunset yellow fcf - moduretic is indicated in the treatment of patients with: - oedema of cardiac origin; - hepatic cirrhosis with ascites; - hypertension in whom potassium depletion might be anticipated. moduretic, with its combination of amiloride hcl and hydrochlorothiazide, minimises the possibility of the development of excessive potassium loss in patients during vigorous diuresis for prolonged periods. moduretic, with its built-in potassium sparing agent, is especially indicated in those conditions where the positive effect on potassium balance is particularly important. moduretic may be used alone, or as an adjunct to other antihypertensive drugs. since it enhances the action of these agents, the dosage of these antihypertensive drugs may need to be reduced to avoid the risk of an excessive drop in blood pressure.

Malaysia - English - NPRA (National Pharmaceutical Regulatory Agency, Bahagian Regulatori Farmasi Negara)

y.s.p. industries (m) sdn. bhd. - sulfachloropyrazine sodium monohydrate -